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Abstract: Citrinin (CIT) and ochratoxin A (OTA) are important mycotoxins, which frequently
co-contaminate foodstuff. In order to assess the toxicologic threat posed by the two mycotoxins
separately or in combination, their biological effects were studied here using genomic transcription
profiling and specific live cell gene expression reporters in yeast cells. Both CIT and OTA cause
highly transient transcriptional activation of different stress genes, which is greatly enhanced by the
disruption of the multidrug exporter Pdr5. Therefore, we performed genome-wide transcription
profiling experiments with the pdr5 mutant in response to acute CIT, OTA, or combined CIT/OTA
exposure. We found that CIT and OTA activate divergent and largely nonoverlapping gene sets
in yeast. CIT mainly caused the rapid induction of antioxidant and drug extrusion-related gene
functions, while OTA mainly deregulated developmental genes related with yeast sporulation and
sexual reproduction, having only a minor effect on the antioxidant response. The simultaneous
exposure to CIT and OTA gave rise to a genomic response, which combined the specific features of
the separated mycotoxin treatments. The application of stress-specific mutants and reporter gene
fusions further confirmed that both mycotoxins have divergent biological effects in cells. Our results
indicate that CIT exposure causes a strong oxidative stress, which triggers a massive transcriptional
antioxidant and drug extrusion response, while OTA mainly deregulates developmental genes and
only marginally induces the antioxidant defense.
Keywords: Ochratoxin A; Citrinin; Transcriptome; Saccharomyces cerevisiae; mycotoxins; oxidative
stress; dose response
1. Introduction
Mycotoxins are small toxic molecules produced by a great variety of microorganism, which
encompass several classes of secondary metabolites with no common chemical structure or mode
of action [1]. These harmful natural products of molds contaminate food and feed worldwide with
appalling economic consequences, since they affect most of the staple food crops such as maize, wheat
and rice [2,3]. Beyond the economic losses, mycotoxins have a severe impact on human wellbeing [4].
Their toxicological properties and possible health effects have been extensively studied and related to
some diseases, although it is certainly difficult to demonstrate the link between toxin exposure and
the onset of symptoms in most cases. Mycotoxins are released by some fungi in nature for unclear
reasons, and although it is widely accepted that the synthesis and secretion of toxins mediate pathogen
virulence of microorganisms in plants, the molecular targets and strategies to achieve it remain to be
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determined in the case of mycotoxins [5]. Considerable efforts have been made to comprehend the
molecular mechanisms of mycotoxins to cause cell damage and toxicity [6–8]. Although it is desirable
to understand the molecular basis of mycotoxin action in whole animals, these approaches are often
difficult because the dose-effect relation depends on many different parameters [7]. As an alternative,
the fundamental modes of toxicity for individual mycotoxins can be efficiently revealed in cell cultures
of lower eukaryotic cells such as yeast.
Ochratoxins are a small group of mycotoxins produced by Aspergillus and Penicillium species,
with ochratoxin A (OTA) as the principal compound, found in a very wide range of raw and processed
food [9]. OTA is nephrotoxic, carcinogenic, and a potent teratogen when tested in different mammalian
models, and thereby is a potential risk to human health [10]. Several authors support that the mode
of action of OTA implies the formation of covalent DNA adducts [11–13] and the increase of reactive
oxygen species [14,15], hence these activities could explain the genotoxic and mutagenic activity of OTA.
The co-occurrence of OTA with citrinin (CIT), another mycotoxin, has been often reported [16,17]. CIT is
produced by filamentous fungi of the genera Penicillium, Aspergillus and Monascus, and contaminates
the same staple foodstuffs as OTA [18]. Fungi such as Penicillium verrucosum are able to produce
both OTA and CIT, however, different environmental conditions might favor the production of one
mycotoxin over the other [19–21]. Much less is known about the toxicity mechanisms of CIT, however,
it has been shown to be an efficient nephrotoxin as well [22]. Several groups have contributed to the
identification of possible molecular mechanisms of CIT toxicity, finding, among other consequences,
the increase of oxidative stress in connection with alterations of mitochondrial function, and induction
of apoptosis [23–31]. It has been proposed that the co-occurrence of both toxins results in synergetic
effects, however no clear conclusions have been reached [32,33].
Gene expression analysis has become a valuable tool to decipher molecular mechanisms in
response to toxic agents, including mycotoxins [34], and the yeast model is particularly important
in toxicogenomic studies [35]. Recent transcriptomic approaches with OTA have been performed
using different cell lines and mammalian model systems [36–39]. A comparison of the genomic data
does not yield a uniform pattern of deregulated genes, and it is striking that DNA damage response
genes are not generally highlighted by these omics approaches [40]. It seems that the variability of the
OTA-induced transcriptomic response might be a consequence of the range of experimental conditions
as well as the cellular context [40]. In contrast to OTA, genomic profiling data for CIT treatment
are scarce, however, the application of yeast microarray approaches has identified the antioxidant
defense as one of the primordial manners of detoxification upon CIT exposure [41]. The transcriptional
response to mycotoxins is likely to be transient and dose dependent, therefore any transcriptomic
assay is further complicated by the selection of the optimal induction conditions. Actually, in vivo
recording of transcriptional activity in Saccharomyces cerevisiae shows a transient dose–time dependent
response to CIT treatment [28].
Given that OTA and CIT are co-occurring toxicological threats in the food chain and that both
overlapping and divergent mechanisms of toxicity have been proposed for both mycotoxins, we aim
here to compare the immediate transcriptomic response to OTA and CIT, applied either separately or
simultaneously. We use an optimized yeast system, where the optimal time point and dose for each
mycotoxin has been adjusted according to live cell gene expression reporters and where the signal
intensity has been largely increased due to the deletion of the principal toxin exporter Pdr5. We identify
largely exclusive patterns of gene deregulation for CIT and OTA, with oxidative stress defense genes
specifically activated by CIT and cell differentiation and developmental genes specifically activated
by OTA.
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2. Results
2.1. Gene Expression Profiles of Stress Response Genes upon CIT and OTA Exposure
We have previously shown that live cell reporter fusions in yeast are valuable and quantitative
tools to characterize the acute transcriptional adaptation to CIT [28]. Here, we extend these studies
to compare the impact of CIT and OTA on the induction of different stress-inducible genes. We used
fusions of the oxidative stress-inducible SOD2 (mitochondrial manganese superoxide dismutase)
promoter and the general stress-inducible GRE2 (methylglyoxal reductase) promoter with destabilized
luciferase as sensitive live cell reporters. Dose-dependent analyses revealed a transient gene expression
profile for both reporter genes, upon treatment with CIT and OTA (Figure 1A). Both mycotoxins
induced gene expression very rapidly within minutes, indicating that CIT and OTA are readily taken
up by yeast cells. However, CIT caused a much broader transcriptional induction, which continuously
increased with dose even beyond 400 ppm (1600 µM). OTA, in contrast, induced the stress-responsive
reporters in a much more transient manner and to much lower absolute induction levels. Moreover,
OTA-induced transcription of GRE2 or SOD2 was already maximal at concentrations around 200 ppm
(497 µM). We next tested the effect of the loss of Pdr5 function, which is a plasma membrane multidrug
transporter critically involved in CIT extrusion [28]. As shown in Figure 1B, the deletion of Pdr5
provokes an enhanced transcriptional response to both CIT and OTA treatment at different doses.
We next wanted to study the level of synergy involved in the response to CIT and OTA using the
same live cell gene expression reporters. Surprisingly, no evident synergistic effect on gene expression
was revealed when both toxins were combined together, both in the wild type or the sensitized pdr5
mutant strain (Figure 1C). Taken together, these results indicated that CIT and OTA had differential
and independent effects on the induction of stress reporters in yeast. Thus we aimed at studying the
differential induction of gene expression upon CIT and OTA exposure at the genomic level.
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Figure 1. Ochratoxin A (OTA) and citrinin (CIT) activate stress gene expression independently and 
with different dose response profiles. (A) OTA and CIT induction of the stress‐activated genes GRE2 
(methylglyoxal  reductase)  and  SOD2  (superoxide  dismutase).  Live  cell  reporter  fusions  with 
Figure 1. Ochratoxin A (OT ) and citrini (CIT tivate stress gene expressio i dependently and
with different dose response profiles. (A) OTA and CIT induction of the stress-activated genes
GRE2 (methylglyoxal reductase) and SOD2 (superoxide dismutase). Live cell reporter fusions with
destabilized luciferase were used in yeast wild type cells and the induction of both genes was measured
in real time upon the indicated mycotoxin doses. (B) The deletion of the Pdr5 multidrug exporter
increases the transcriptional response to both OTA and CIT. The expression profiles for the GRE2
and SOD2 genes are compared for wild type and the pdr5 deletion mutant upon the indicated
mycotoxin doses. (C) OTA and CIT do not activate stress gene expression in a synergistic manner.
The dose response profiles of (A) and (B) are represented here as the maximal activity (Amax) for each
mycotoxin dose. Additionally (purple columns at the right of each plot), a constant concentration
of CIT (50 ppm = 200 µM) was combined with growing concentrations of OTA (50 ppm = 124 µM;
200 ppm = 497 µM; 400 ppm = 994 µM) as indicated. All gene expression experiments were performed
on three independent culture aliquots; the Standard Deviation was <15%; error bars are not included in
the graphs in order to make the figure clearly visible.
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2.2. Genomic Expression Profiles upon Separated and Combined Exposure to CIT and OTA
Our previous study of specific stress promoters suggested that CIT and OTA had a different
impact on gene expression. Both mycotoxins, however, activate gene transcription in a very transient
manner. We wanted to take advantage of genome-wide transcription analysis in yeast to gain insights
into the differential induction of gene expression triggered by the two mycotoxins. The microarray
experiments were performed in the sensitized pdr5 mutant strain and at optimized toxin concentrations
and exposure times as revealed by our real time surveys upon acute CIT and OTA exposure.
The transcriptomic response of yeast was determined by microarray hybridization upon separated CIT
and OTA exposure (200 ppm) as well as upon the combined addition of CIT/OTA (100 ppm each).
As a first approach, we identified and ranked the most upregulated genes for each toxin treatment.
We applied a very stringent cutoff value and considered only the genes which were expressed more
than 5-fold higher in the treated cells as compared to the untreated cells. The resulting gene lists are
represented in Table 1 for CIT, in Table 2 for OTA, and in Table 3 for the combined CIT/OTA treatment.
Table 1. Genes > 5-fold upregulated upon CIT (citrinin) exposure.
Gene Standard Name FC * p-Value Description
YPL171C OYE3 473.1 3.00 × 10−8 Conserved NADPH oxidoreductase containing flavinmononucleotide (FMN)
YFL056C AAD6 252.4 9.60 × 10−7 Putative aryl-alcohol dehydrogenase
YDL243C AAD4 252.1 1.77 × 10−9 Putative aryl-alcohol dehydrogenase
YCL026C-A FRM2 177.2 1.77 × 10−5 Type II nitroreductase
YLL060C GTT2 142.4 4.50 × 10−5 Glutathione S-transferase
YBR008C FLR1 120.6 1.83 × 10−7 Plasma membrane multidrug transporter of the majorfacilitator superfamily
YCL026C-B HBN1 61.7 1.81 × 10−6 Protein of unknown function
YGR213C RTA1 57.8 1.77 × 10−8 Protein involved in 7-aminocholesterol resistance
YML116W ATR1 54.8 1.45 × 10−7 Multidrug efflux pump of the major facilitator superfamily
YKR076W ECM4 51.6 6.10 × 10−6 Omega class glutathione transferase
YML131W - 41.2 9.44 × 10−3 Protein of unknown function
YHR139C SPS100 35.2 4.78 × 10−7 Protein required for spore wall maturation
YFL057C AAD16 33.5 2.12 × 10−2 Putative aryl-alcohol dehydrogenase
YDR011W SNQ2 31.1 6.78 × 10−7 Plasma membrane ATP-binding cassette (ABC) transporter
YOL151W GRE2 25.8 2.28 × 10−6 3-methylbutanal reductase and NADPH-dependentmethylglyoxal reductase
YKL086W SRX1 25.6 5.22 × 10−7 Sulfiredoxin
YDR406W PDR15 18.1 1.12 × 10−6 Plasma membrane ATP binding cassette (ABC) transporter
YLR108C - 16.6 5.77 × 10−8 Protein of unknown function
YDL020C RPN4 15.8 9.41 × 10−8 Transcription factor that stimulates expression of proteasome genes
YNL117W MLS1 15.1 3.95 × 10−6 Malate synthase
YOR328W PDR10 14.5 2.41 × 10−8 ATP-binding cassette (ABC) transporter
YHR199C AIM46 13.3 1.58 × 10−7 Putative protein of unknown function
YHR029C YHI9 12.9 3.86 × 10−7 Protein of unknown function
YGR256W GND2 10.9 5.58 × 10−7 6-phosphogluconate dehydrogenase
YBR244W GPX2 10.5 3.56 × 10−6 Phospholipid hydroperoxide glutathione peroxidase
YFL030W AGX1 10.3 4.28 × 10−8 Alanine:glyoxylate aminotransferase (AGT)
YDR453C TSA2 9.6 2.01 × 10−7 Stress inducible cytoplasmic thioredoxin peroxidase
YER143W DDI1 9.5 8.66 × 10−5 DNA damage-inducible v-SNARE binding protein
YNR074C AIF1 9.1 4.46 × 10−7 Mitochondrial cell death effector
YER042W MXR1 9.0 2.11 × 10−6 Methionine-S-sulfoxide reductase
YJL101C GSH1 8.9 1.30 × 10−7 Gamma glutamylcysteine synthetase
YHR138C - 8.8 1.42 × 10−3 Protein of unknown function
YHL036W MUP3 8.6 1.13 × 10−5 Low affinity methionine permease
YNL129W NRK1 8.5 1.61 × 10−5 Nicotinamide riboside kinase
YPR200C ARR2 8.1 1.57 × 10−4 Arsenate reductase
YER103W SSA4 7.8 2.65 × 10−5 Heat shock protein
YJL045W - 7.7 3.32 × 10−7 Minor succinate dehydrogenase isozyme
YPL027W SMA1 7.7 9.86 × 10−7 Protein of unknown function involved in prosporemembrane assembly
YGR010W NMA2 7.5 1.02 × 10−7 Nicotinic acid mononucleotide adenylyltransferase
YMR169C ALD3 7.4 6.10 × 10−4 Cytoplasmic aldehyde dehydrogenase
YDR132C - 7.3 1.74 × 10−6 Protein of unknown function
YOR162C YRR1 7.2 1.24 × 10−7 Zn2-Cys6 zinc-finger transcription factor
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Table 1. Cont.
Gene Standard Name FC * p-Value Description
YMR038C CCS1 6.9 6.96 × 10−5 Copper chaperone for superoxide dismutase Sod1p
YJL219W HXT9 6.9 1.67 × 10−7 Putative hexose transporter
YER142C MAG1 6.8 5.46 × 10−7 3-methyl-adenine DNA glycosylase
YBR046C ZTA1 6.7 1.13 × 10−5 NADPH-dependent quinone reductase
YNL231C PDR16 6.6 7.41 × 10−3 Phosphatidylinositol transfer protein (PITP)
YPL091W GLR1 6.5 1.49 × 10−5 Cytosolic and mitochondrial glutathione oxidoreductase
YGR281W YOR1 6.4 2.16 × 10−3 Plasma membrane ATP-binding cassette (ABC) transporter
YGR197C SNG1 6.3 3.47 × 10−7 Protein involved in resistance to nitrosoguanidine and 6-azauracil
YNL155W CUZ1 6.1 5.38 × 10−3 Protein with a role in the ubiquitin-proteasome pathway
YAL054C ACS1 6.1 3.74 × 10−7 Acetyl-coA synthetase isoform
YOL119C MCH4 6.1 1.27 × 10−5 Protein with similarity to mammalian monocarboxylate permeases
YDL168W SFA1 6.0 1.21 × 10−5 Bifunctional alcohol dehydrogenase andformaldehyde dehydrogenase
YCR021C HSP30 6.0 5.37 × 10−3 Negative regulator of the H(+)-ATPase Pma1p
YBR256C RIB5 5.9 1.15 × 10−3 Riboflavin synthase
YOR052C TMC1 5.8 9.56 × 10−3 AN1-type zinc finger protein of unknown function
YOL155C HPF1 5.8 6.09 × 10−5 Haze-protective mannoprotein
YMR318C ADH6 5.8 7.64 × 10−3 NADPH-dependent medium chain alcohol dehydrogenase
YJL082W IML2 5.8 4.56 × 10−4 Protein of unknown function
YKL051W SFK1 5.6 6.62 × 10−6 Plasma membrane protein that may act to generate normallevels of PI4P
YER185W PUG1 5.6 3.14 × 10−5 Plasma membrane protein involved in protoprophyrin andheme transport
YIR017C MET28 5.6 3.48 × 10−6 Basic leucine zipper (bZIP) transcriptional activator in theCbf1p-Met4p-Met28p complex
YHL024W RIM4 5.5 4.66 × 10−6 Putative RNA-binding protein
YGR243W MPC3 5.4 7.07 × 10−5 Highly conserved subunit of mitochondrial pyruvate carrier
YGL010W MPO1 5.3 7.58 × 10−6 Protein involved in metabolism of phytosphingosine
YDR513W GRX2 5.1 6.09 × 10−3 Cytoplasmic glutaredoxin
YHR179W OYE2 5.1 1.04 × 10−2 Conserved NADPH oxidoreductase containing flavinmononucleotide (FMN)
YDR059C UBC5 5.1 2.39 × 10−4 Ubiquitin-conjugating enzyme
YMR276W DSK2 5.0 5.01 × 10−3 Nuclear-enriched ubiquitin-like polyubiquitin-binding protein
* Fold change (FC) refers to the fold induction of the genes as compared to the untreated control.
Table 2. Genes > 5-fold upregulated upon OTA (ochratoxin A) exposure.
Gene Standard Name FC * p-Value Description
YER106W MAM1 60.2 2.77 × 10−8 Monopolin
YGR225W AMA1 57.4 9.19 × 10−10 Activator of meiotic anaphase promoting complex (APC/C)
YER179W DMC1 40.5 5.34 × 10−7 Meiosis-specific recombinase
YOR298W MUM3 33.5 9.62 × 10−4 Protein of unknown function
YFL011W HXT10 33.2 1.38 × 10−7 Putative hexose transporter
YLL046C RNP1 27.3 1.08 × 10−7 Ribonucleoprotein
YER104W RTT105 26.0 3.22 × 10−8 Protein with a role in regulation of Ty1 transposition
YLR377C FBP1 23.3 1.62 × 10−7 Fructose-1,6-bisphosphatase
YDR523C SPS1 22.7 6.27 × 10−6 Putative protein serine/threonine kinase
YHR176W FMO1 20.2 1.11 × 10−5 Flavin-containing monooxygenase
YBR040W FIG1 19.7 1.16 × 10−7 Integral membrane protein
YGR059W SPR3 18.6 4.74 × 10−5 septin protein involved in sporulation
YEL039C CYC7 16.9 6.54 × 10−7 Cytochrome c isoform 2
YMR101C SRT1 16.7 3.73 × 10−7 Forms the dehydrodolichyl diphosphate syntase (DDS) complexwith NUS1
YDR218C SPR28 14.1 1.11 × 10−6 Meiotic septin
YDR256C CTA1 13.5 7.51 × 10−8 Catalase A
YIL113W SDP1 13.3 2.62 × 10−7 Stress-inducible dual-specificity MAP kinase phosphatase
YOL123W HRP1 12.9 1.98 × 10−6 Subunit of cleavage factor I complex
YGL254W FZF1 12.6 2.03 × 10−7 Transcription factor involved in sulfite metabolism
YPL201C YIG1 12.4 3.23 × 10−5 Protein that interacts with glycerol 3-phosphatase
Q0275 COX3 12.3 1.01 × 10−4 Subunit III of cytochrome c oxidase (Complex IV)
YFL055W AGP3 12.3 2.34 × 10−6 Low-affinity amino acid permease
YDR259C YAP6 11.4 1.88 × 10−5 Basic leucine zipper (bZIP) transcription factor
YPR193C HPA2 11.3 2.74 × 10−5 Tetrameric histone acetyltransferase
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Table 2. Cont.
Gene Standard Name FC * p-Value Description
YOR378W AMF1 11.3 2.33 × 10−6 Low affinity NH4+ transporter
YLL042C ATG10 11.3 3.47 × 10−6 Conserved E2-like conjugating enzyme
YIL101C XBP1 11.1 3.43 × 10−4 Transcriptional repressor
YBR018C GAL7 11.0 2.12 × 10−5 Galactose-1-phosphate uridyl transferase
YEL019C MMS21 10.9 6.11 × 10−6 SUMO ligase and component of the SMC5-SMC6 complex
YPR040W TIP41 10.9 3.19 × 10−5 Protein that interacts with Tap42p
YPL033C SRL4 10.7 1.75 × 10−6 Protein of unknown function
YLL057C JLP1 10.5 1.82 × 10−6 Fe(II)-dependent sulfonate/alpha-ketoglutarate dioxygenase
YGR142W BTN2 10.3 2.34 × 10−5 v-SNARE binding protein
YPL279C FEX2 10.3 2.64 × 10−7 Protein involved in fluoride export
YHL022C SPO11 10.2 2.70 × 10−7 Meiosis-specific protein
YKL055C OAR1 10.0 2.10 × 10−6 Mitochondrial 3-oxoacyl-[acyl-carrier-protein] reductase
YNL009W IDP3 10.0 1.42 × 10−2 Peroxisomal NADP-dependent isocitrate dehydrogenase
YOR297C TIM18 9.9 3.75 × 10−5 Component of the mitochondrial TIM22 complex
YER053C-A - 9.8 7.45 × 10−6 Protein of unknown function
YPL027W SMA1 9.7 1.50 × 10−7 Protein of unknown function
YBR074W PFF1 9.6 5.70 × 10−6 Multi-spanning vacuolar membrane protease
YEL048C TCA17 9.6 2.14 × 10−7 Component of transport protein particle (TRAPP) complex II
YGR197C SNG1 9.2 7.32 × 10−8 Protein involved in resistance to nitrosoguanidine and 6-azauracil
YJR047C ANB1 9.2 1.29 × 10−6 Translation elongation factor eIF-5A
YKL093W MBR1 9.0 3.41 × 10−5 Protein involved in mitochondrial functions and stress response
YGR212W SLI1 9.0 2.03 × 10−5 N-acetyltransferase
YCL026C-A FRM2 8.8 1.66 × 10−6 Type II nitroreductase
YEL072W RMD6 8.7 6.39 × 10−7 Protein required for sporulation
YML054C CYB2 8.5 2.74 × 10−6 Cytochrome b2 (L-lactate cytochrome-c oxidoreductase)
YNL187W SWT21 8.5 6.08 × 10−6 Protein involved in mRNA splicing
YNR064C - 8.5 1.99 × 10−5 Epoxide hydrolase
YBR065C ECM2 8.4 9.49 × 10−6 Pre-mRNA splicing factor
YPL171C OYE3 8.4 6.43 × 10−6 Conserved NADPH oxidoreductase containing flavinmononucleotide (FMN)
YGL212W VAM7 8.4 1.02 × 10−4 Vacuolar SNARE protein
YOR390W FEX1 8.2 3.59 × 10−6 Protein involved in fluoride export
YMR069W NAT4 8.1 1.76 × 10−4 N-alpha-acetyl-transferase
YDL020C RPN4 8.0 3.51 × 10−7 Transcription factor that stimulates expression of proteasome genes
YDR171W HSP42 8.0 6.87 × 10−6 Small heat shock protein (sHSP) with chaperone activity
YER054C GIP2 7.9 2.59 × 10−6 Putative regulatory subunit of protein phosphatase Glc7p
YPR151C SUE1 7.9 9.84 × 10−7 Protein required for degradation of unstable forms of cytochrome c
YGR131W FHN1 7.7 1.62 × 10−6 Protein of unknown function
YEL061C CIN8 7.6 1.15 × 10−5 Kinesin motor protein
YDR079W PET100 7.6 4.29 × 10−6 Chaperone that specifically facilitates the assembly ofcytochrome c oxidase
YKL051W SFK1 7.6 1.38 × 10−4 Plasma membrane protein
YMR017W SPO20 7.5 1.72 × 10−3 Meiosis-specific subunit of the t-SNARE complex
YDR011W SNQ2 7.5 4.53 × 10−7 Plasma membrane ATP-binding cassette (ABC) transporter
YOR152C ATG40 7.4 4.01 × 10−5 Autophagy receptor
YLR312C ATG39 7.4 2.53 × 10−7 Autophagy receptor
YBL078C ATG8 7.3 7.40 × 10−7 Component of autophagosomes and Cvt vesicles
YPL186C UIP4 7.2 4.47 × 10−4 Protein that interacts with Ulp1p
YLR142W PUT1 7.1 2.11 × 10−6 Proline oxidase
YOR065W CYT1 7.0 4.71 × 10−5 Cytochrome c1
YOL149W DCP1 7.0 1.35 × 10−3 Subunit of the Dcp1p-Dcp2p decapping enzyme complex
Q0250 COX2 6.7 3.78 × 10−2 Subunit II of cytochrome c oxidase (Complex IV)
YDR402C DIT2 6.6 1.08 × 10−3 N-formyltyrosine oxidase
YGR243W MPC3 6.6 1.70 × 10−5 Highly conserved subunit of the mitochondrial pyruvatecarrier (MPC)
YOR005C DNL4 6.6 5.57 × 10−6 DNA ligase
YJR010W MET3 6.6 9.83 × 10−7 ATP sulfurylase
YLR151C PCD1 6.5 2.79 × 10−6 8-oxo-dGTP diphosphatase
YNL158W PGA1 6.3 4.04 × 10−4 Essential component of GPI-mannosyltransferase II
YDR524C AGE1 6.3 8.02 × 10−7 ADP-ribosylation factor (ARF) GTPase activating protein(GAP) effector
YNL012W SPO1 6.3 4.68 × 10−6 Meiosis-specific prospore protein
YGL240W DOC1 6.3 6.44 × 10−5 Processivity factor
YDR076W RAD55 6.3 1.32 × 10−4 Protein that stimulates strand exchange
YOR192C THI72 6.3 7.85 × 10−6 Transporter of thiamine or related compound
YMR251W GTO3 6.3 2.35 × 10−5 Omega class glutathione transferase
YDR185C UPS3 6.2 4.77 × 10−6 Mitochondrial protein of unknown function
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Table 2. Cont.
Gene Standard Name FC * p-Value Description
YNL014W HEF3 6.2 1.32 × 10−4 Translational elongation factor EF-3
YML087C AIM33 6.2 1.01 × 10−4 Putative protein of unknown function
YNR034W SOL1 6.2 7.19 × 10−7 Protein with a possible role in tRNA export
YDR070C FMP16 6.1 3.24 × 10−4 Protein of unknown function
YJR129C EFM3 6.1 4.06 × 10−2 S-adenosylmethionine-dependent methyltransferase
Q0045 COX1 6.0 1.76 × 10−2 Subunit I of cytochrome c oxidase (Complex IV)
YNL036W NCE103 5.9 4.88 × 10−5 Carbonic anhydrase
YOR178C GAC1 5.9 6.08 × 10−4 Regulatory subunit for Glc7p type-1 protein phosphatase (PP1)
YGR088W CTT1 5.9 8.13 × 10−5 Cytosolic catalase T
YDL247W MPH2 5.8 2.28 × 10−5 Alpha-glucoside permease
YCL066W HMLALPHA1 5.7 6.90 × 10−4 Silenced copy of ALPHA1 at HML
YNL077W APJ1 5.6 3.33 × 10−6 Chaperone with a role in SUMO-mediated protein degradation
YKL095W YJU2 5.6 1.29 × 10−3 Essential protein required for pre-mRNA splicing
YJL030W MAD2 5.6 1.64 × 10−4 Component of the spindle-assembly checkpoint complex
YHL016C DUR3 5.6 9.87 × 10−7 Plasma membrane transporter for urea and polyamines
YNL188W KAR1 5.6 1.64 × 10−4 Protein involved in karyogamy and spindle pole body duplication
YGR234W YHB1 5.6 1.02 × 10−5 Nitric oxide oxidoreductase
YCR040W MATALPHA1 5.5 6.76 × 10−4 Transcriptional co-activator that regulatesmating-type-specific genes
YFL016C MDJ1 5.5 2.05 × 10−4 Co-chaperone that stimulates HSP70 protein Ssc1p ATPase activity
YNL194C - 5.4 4.89 × 10−4 Integral membrane protein
YDR475C JIP4 5.3 2.01 × 10−3 Protein of unknown function
YJR160C MPH3 5.3 8.87 × 10−5 Alpha-glucoside permease
YCR104W PAU3 5.3 1.92 × 10−3 Member of the seripauperin multigene family
YIL084C SDS3 5.3 6.30 × 10−6 Component of the Rpd3L histone deacetylase complex
YIL056W VHR1 5.1 3.53 × 10−3 Transcriptional activator
YAR020C PAU7 5.0 1.56 × 10−4 Member of the seripauperin multigene family
YDR227W SIR4 5.0 1.71 × 10−5 Silent information regulator
YLR376C PSY3 5.0 6.70 × 10−6 Component of Shu complex (aka PCSS complex)
* Fold change (FC) refers to the fold induction of the genes as compared to the untreated control.
Table 3. Genes > 5-fold upregulated upon the combined CIT/OTA exposure.
Gene Standard Name FC * p-Value Description
YPL171C OYE3 199.6 1.29 × 10−4 Conserved NADPH oxidoreductase containing flavinmononucleotide (FMN)
YDL243C AAD4 46.5 1.49 × 10−9 Putative aryl-alcohol dehydrogenase
YFL056C AAD6 41.2 1.16 × 10−7 Putative aryl-alcohol dehydrogenase
YLL060C GTT2 34.6 1.44 × 10−9 Glutathione S-transferase capable of homodimerization
YBR008C FLR1 28.0 1.21 × 10−7 Plasma membrane transporter of the major facilitator superfamily
YML131W - 24.2 2.41 × 10−6 Protein of unknown function
YOL151W GRE2 21.9 1.17 × 10−4 3-methylbutanal reductase and NADPH-dependentmethylglyoxal reductase
YCL026C-A FRM2 21.5 1.53 × 10−8 Type II nitroreductase
YMR101C SRT1 21.3 2.64 × 10−8 Forms the dehydrodolichyl diphosphate syntase (DDS) complexwith NUS1
YGR225W AMA1 20.5 3.87 × 10−7 Activator of meiotic anaphase promoting complex (APC/C)
YDL020C RPN4 19.5 4.24 × 10−4 Transcription factor that stimulates expression of proteasome genes
YDR256C CTA1 18.8 4.53 × 10−9 Catalase A
YGR197C SNG1 18.7 5.35 × 10−9 Protein involved in resistance to nitrosoguanidine and 6-azauracil
YKL051W SFK1 18.7 6.62 × 10−8 Plasma membrane protein that may act to generate normallevels of PI4P
YML116W ATR1 16.3 9.44 × 10−6 Multidrug efflux pump of the major facilitator superfamily
YGR142W BTN2 15.2 7.12 × 10−6 v-SNARE binding protein
YHR087W RTC3 15.0 1.01 × 10−6 Protein of unknown function involved in RNA metabolism
YDR406W PDR15 14.2 3.31 × 10−6 Plasma membrane ATP binding cassette (ABC) transporter
YFL057C AAD16 13.7 1.51 × 10−5 Putative aryl-alcohol dehydrogenase
YOL149W DCP1 13.5 3.61 × 10−5 Subunit of the Dcp1p-Dcp2p decapping enzyme complex
YDR171W HSP42 13.5 1.19 × 10−3 Small heat shock protein (sHSP) with chaperone activity
YIL101C XBP1 12.3 3.01 × 10−5 Transcriptional repressor
YHR139C SPS100 12.3 1.95 × 10−7 Protein required for spore wall maturation
YGR213C RTA1 12.1 1.04 × 10−8 Protein involved in 7-aminocholesterol resistance
YEL039C CYC7 11.8 4.14 × 10−8 Cytochrome c isoform 2
YIL056W VHR1 10.5 4.95 × 10−7 Transcriptional activator
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Table 3. Cont.
Gene Standard Name FC * p-Value Description
YCL026C-B HBN1 10.5 8.33 × 10−6 Protein of unknown function
YOL123W HRP1 10.4 2.81 × 10−6 Subunit of cleavage factor I
YHL036W MUP3 9.5 6.44 × 10−7 Low affinity methionine permease
YKR076W ECM4 9.4 4.12 × 10−7 Omega class glutathione transferase
YLR108C - 9.1 3.50 × 10−7 Protein of unknown function
YER054C GIP2 8.9 1.55 × 10−7 Putative regulatory subunit of protein phosphatase Glc7p
YOR298W MUM3 8.9 3.49 × 10−6 Protein of unknown function involved in outer sporewall organization
YHL024W RIM4 8.6 4.31 × 10−8 Putative RNA-binding protein
YMR169C ALD3 8.3 6.99 × 10−3 Cytoplasmic aldehyde dehydrogenase
YOR028C CIN5 8.2 2.47 × 10−7 Basic leucine zipper (bZIP) transcription factor of the yAP-1 family
YGR088W CTT1 8.1 3.34 × 10−6 Cytosolic catalase T
YER103W SSA4 8.0 1.02 × 10−5 Heat shock protein member of the HSP70 family
YER185W PUG1 7.5 1.07 × 10−5 Plasma membrane protein involved in protoprophyrin andheme transport
YER053C-A - 7.2 1.56 × 10−4 Protein of unknown function
YOR152C ATG40 7.2 3.92 × 10−5 Autophagy receptor
YDL204W RTN2 6.7 1.74 × 10−6 Reticulon protein
YOR065W CYT1 6.6 4.43 × 10−6 Cytochrome c1
YJL051W IRC8 6.6 5.68 × 10−5 Bud tip localized protein of unknown function
YLR329W REC102 6.5 4.83 × 10−6 Protein involved in early stages of meiotic recombination
YKR077W MSA2 6.4 6.97 × 10−6 Putative transcriptional activator
YHR138C - 6.1 7.19 × 10−3 Protein of unknown function
YPL201C YIG1 6.0 4.46 × 10−7 Protein that interacts with glycerol 3-phosphatase
YDL025C RTK1 6.0 3.61 × 10−2 Putative protein kinase
YOR178C GAC1 5.9 9.69 × 10−4 Regulatory subunit for Glc7p type-1 protein phosphatase (PP1)
YFL016C MDJ1 5.8 4.14 × 10−5 Co-chaperone member of the HSP40 (DnaJ) family of chaperones
YFL030W AGX1 5.8 1.51 × 10−6 Alanine:glyoxylate aminotransferase (AGT)
YKL086W SRX1 5.8 5.28 × 10−5 Sulfiredoxin
YOR328W PDR10 5.8 1.96 × 10−6 ATP-binding cassette (ABC) transporter
YPR151C SUE1 5.6 1.71 × 10−7 Protein required for degradation of unstable forms of cytochrome c
YLL026W HSP104 5.5 4.85 × 10−2 Disaggregase
YGR243W MPC3 5.5 5.30 × 10−5 Highly conserved subunit of the mitochondrial pyruvatecarrier (MPC)
YKL093W MBR1 5.5 2.19 × 10−5 Protein involved in mitochondrial functions and stress response
YNL036W NCE103 5.5 5.13 × 10−5 Carbonic anhydrase
YNL008C ASI3 5.5 1.69 × 10−5 Subunit of the nuclear inner membrane Asi ubiquitinligase complex
YLR343W GAS2 5.5 4.37 × 10−6 1,3-beta-glucanosyltransferase
YGR223C HSV2 5.4 1.69 × 10−6 Phosphatidylinositol 3,5-bisphosphate-binding protein
YER060W-A FCY22 5.2 1.17 × 10−5 Putative purine-cytosine permease
YNL155W CUZ1 5.2 1.90 × 10−3 Protein with a role in the ubiquitin-proteasome pathway
YHL021C AIM17 5.2 1.36 × 10−4 Putative protein of unknown function
YHR199C AIM46 5.2 1.08 × 10−5 Putative protein of unknown function
YGR281W YOR1 5.1 2.18 × 10−3 Plasma membrane ATP-binding cassette (ABC) transporter
YGL010W MPO1 5.1 3.53 × 10−6 Protein involved in metabolism of phytosphingosine
* Fold change (FC) refers to the fold induction of the genes as compared to the untreated control.
Acute CIT exposure provoked the robust upregulation of 68 yeast genes. When classified for
the most statistically relevant functional groups, we identified the response to oxidative stress as
the dominant group (see Table 4). These data confirmed that CIT toxicity is fundamentally based
on its capacity to generate reactive oxygen species (ROS) in cells. Specifically, genes involved in
the metabolism of glutathione were preferentially expressed upon CIT exposure, indicating that the
antioxidant function of glutathione was necessary to palliate the toxic effect of CIT. Additionally we
identified “Drug transport” as a main CIT-inducible gene group, suggesting that the activated export
of the toxin might be a major determinant for the adaptation of yeast cells to CIT.
For OTA exposure, we were able to identify 115 genes whose expression was at least 5-fold induced
(Table 2). The analysis of the functional groups enriched in the dataset derived from OTA-treated cells
revealed that the “response to oxidative stress” was retrieved with much less significance as compared
to the CIT dataset. In turn, we identified yet other functional groups as most significantly upregulated
by OTA, which belong to developmental processes of yeast cells and specifically to the differentiation
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processes of sporulation and reproduction (see Table 4). These data indicated that both mycotoxins
induced different gene sets in yeast. Indeed, the comparison of the most significantly upregulated
genes revealed that less than 5% (a total of only 8 genes) of the transcripts were induced commonly by
either CIT or OTA as depicted in Figure 2. The subset of CIT- and OTA-responsive genes was enriched
for the functional category “Oxidation–reduction process”. These results clearly showed that CIT and
OTA induced largely separated gene sets in the initial adaptive phase, which suggested that both
mycotoxins might have different biological effects in yeast cells. We next analyzed the transcriptomic
response of yeast cells to the combined exposure of CIT and OTA. A total of 68 transcripts were
significantly upregulated >5-fold under these conditions (see Table 3). The functional gene groups
enriched by the combined mycotoxin treatment represented a combination of the gene functions
induced in the previous experiments by the separated toxin treatment. As a result, all categories
covering “oxidative stress response”, “drug transport”, “developmental processes”, and “sporulation”
were significantly enriched upon the combined CIT/OTA exposure (see Table 4). Taken together,
our transcriptomic survey of the response to CIT and OTA strongly supported the idea that both toxins
cause distinct and separable biological responses. CIT caused a clear antioxidant response and the
induction of multiple drug extrusion systems, while OTA seemed to retain a weak oxidation-related
toxicity and to cause a marked deregulation of developmental genes. We wanted to further dissect
these divergent toxicity effects of CIT and OTA in the yeast model.
Table 4. Functional gene groups induced by the separated or combined exposure to CIT and OTA.
CIT
p-value
Gene Ontology Group
Oxidation-reduction process 1.8 × 10−13
Cell response to oxidative stress 2.2 × 10−9
Glutathione metabolic process 1.8 × 10−6
Drug transport 1.3 × 10−5
Response to reactive oxygen species 1.3 × 10−4
OTA
p-value
Gene Ontology Group
Single organism developmental process 2.2 × 10−8
Oxidation-reduction process 2.0 × 10−7
Cell differentiation 3.0 × 10−6
Developmental process involved in reproduction 5.4 × 10−6
Sporulation 1.6 × 10−5
Cell response to oxidative stress 5.4 × 10−3
CIT + OTA
p-value
Gene Ontology Group
Oxidation-reduction process 1.7 × 10−7
Drug transport 1.3 × 10−5
Cell response to oxidative stress 3.1 × 10−4
Spore wall assembly 1.4 × 10−3
Single organism developmental process 4.2 × 10−3
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yeast cells, while antioxidant genes were only weakly induced by OTA. Additionally, CIT
rob stly induced the expressi n of a total of 7 different multidrug expo ters (Flr1, Atr1, Snq2, 5,
0, P r16 and Yor1), while OTA moderately activated the expression of only th Snq2 drug
exporter. We therefore wanted to quantify the importance of the a tioxidant respo e and drug
transport for the resistance to CIT or OTA. We employed specific yeast mutants with a efect in the
oxidative stress adaptation (yap1, skn7) or multidrug export ( nq2, yor1) and tested their resistance
t CIT or OTA in comparison to wild type cells. As shown in Figure 3, the la k of the principal
transcript onal activator of the oxidative stress defense Yap1 or of th multidrug transporter Snq2
rendered yeast cells hypersensitive to CIT, but not OTA. This sensitivity was observed aft r 8 h of toxin
tr atment. Th deletion of a second transcription factor i v lved in the a tioxidant response, Skn7,
or an alternative multidrug xporter, Yor1, result d in a weak r sensitivity phenotype x lusively in
the ase of CIT, which was observed after a prolonged toxin treatment (24 h). These data indica ed
that the antioxidant defense and the activated toxin export are key features for CIT detoxification,
which are dispensable for the cellular defense against OTA.
We next wanted to test whether CIT and OTA caused different biological effects in the first
instances of exposure. We therefore applied different live cell gene expression reporters in yeast cells
to monitor transcriptional responses, which are triggered by distinct biological stimuli. Since we have
previously shown that the Pdr5 drug transporter is important for the response to both CIT and OTA,
we used a PDR5–luciferase expressing strain to monitor the induction of PDR5, which is activated
by the accumulation of both toxins in the cell interior and not linked to a specific type of stress.
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Furthermore, we recorded the activation of two additional reporters, the general stress-inducible
GRE2–luciferase, and the oxidative stress-inducible AP1–luciferase fusion [42]. We obtained the
complete dose-response profiles of all three reporter strains upon increasing CIT and OTA exposures
(Figure 4A). The relationship between the toxin dose and the transcriptional output (Amax) allowed us
to visualize the relative sensibilities, with which each reporter was activated by the two mycotoxins
(Figure 4B), and to observe important differences. Both CIT and OTA induced the PDR5–lucCP
reporter with similar dose-response kinetics. However, the stress-specific GRE2 and AP1 reporters
were activated by CIT in a much more sensitive manner as compared to OTA (Figure 4B). Remarkably,
the oxidative stress specific AP1–luciferase reporter remained completely uninduced even at the
highest OTA concentrations. These data, together with the previous phenotypic analysis of specific
yeast mutants, clearly indicated that CIT and OTA have divergent biological effects in cells. Taking
together all the results presented here, CIT exposure causes strong oxidative stress, which triggers
a massive transcriptional antioxidant and drug extrusion response, while OTA mainly deregulates
developmental genes and only marginally induces the antioxidant defense.
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Figure 3. Citrinin, but not ochratoxin A, toxicity is exacerbated in mutants with a defective antioxidant
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3. iscussion
Here we compare the toxicity targets of the mycotoxins ochratoxin A and citrinin using yeast
as a model. Saccharomyces cerevisiae is a very suitable organism to investigate the adaptive response
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triggered by OTA and CIT, because both toxins cause rapid and profound changes in gene expression
in yeast. Moreover, yeast transcriptional responses can be compared quantitatively in real time
for different stress-specific reporters and additionally on a genomic scale. These approaches are
thus suitable as a diagnostic tool to discern divergent and common biological effects of toxins. It is
important to note that yeast cells seem to resist much higher CIT and OTA doses as compared to
mammalian cells. The reasons for this might be a very efficient extrusion by multidrug transporters
in this organism—which is shown here as being especially relevant for CIT detoxification—or the
function of the yeast cell wall, which might serve as a primary barrier for mycotoxins. The adsorption
by the yeast cell wall is actually an emerging biotechnological approach to control the concentration of
different mycotoxins including OTA [43,44].
A common defense strategy of eukaryotic cells against many unrelated toxic compounds and
xenobiotics is the activation of multidrug transporters at the plasma membrane [45,46]. In yeast cells,
such as in other fungi and human cells, the intracellular levels of toxic molecules are directly sensed by
specialized transcription factors, which in turn activate the expression of multidrug transporter genes
in an attempt to physically extrude the toxic agents from the cell interior [47]. Here we take advantage
of a specific drug efflux pump, Pdr5, which seems to be important for both CIT and OTA detoxification.
Mutants for Pdr5 respond in a much more sensitive manner to both mycotoxins, as indicated by a more
pronounced transcriptional activation of stress reporters by lower toxin concentrations. Although
not tested directly, we assume that pdr5 mutant cells accumulate higher CIT and OTA concentrations.
We took advantage of this sensitivity phenotype to carry out genomic profiling experiments. The use
of a hypersensitive mutant strain and the selection of optimized toxin concentrations and time points
for sample preparation favored the identification of many significantly deregulated gene functions
in the immediate response to both compounds. We show that the expression of the PDR5 gene is
activated by CIT and OTA with similar dose response profiles (Figure 3B). This result indicates that
both mycotoxins are similarly taken up by yeast cells and that the differences in the gene expression
profiles are not due to a differential intracellular accumulation of the two compounds.
Citrinin induces the expression of many different multidrug transporters, and the functional
category “Drug membrane transport” is significantly enriched among the CIT target genes. Seven
multidrug exporter genes are highly induced by CIT: FLR1, ATR1, SNQ2, PDR15, PDR10, PDR16,
and YOR1. All of these transporters are localized, at least in part, at the plasma membrane. Thus the
inducible active transport of CIT from the cytosol to the cell exterior is an important feature of
detoxification of this mycotoxin in yeast cells. Accordingly, we detect an increased sensitivity to CIT
by the loss of individual transporters such as Pdr5, Snq2 or Yor1. OTA, however, has a much weaker
impact on the induction of the multidrug extrusion system, which coincides with the CIT response only
in the moderate induction of the SNQ2 gene. Of note, the yeast pleiotropic drug response is activated
by the mere presence of the compound in the cell interior and also by the cytotoxic stress triggered
by the compound. Thus the higher impact of CIT on the ROS balance of the cell as compared to OTA
could result in a much more profound transcriptional activation of the multidrug export system.
Here we show that the predominant mechanism of CIT toxicity is the induction of oxidative
stress. Moreover, oxidative stress reporters are immediately upregulated upon CIT exposure and
yeast mutants with a weakened antioxidant defense are hypersensitive to this mycotoxin, which
altogether suggests that the induction of ROS inside cells is a primary mode of CIT action. Our result
is in agreement with a previous transcriptomic assay in yeast upon prolonged CIT treatment [41]
and with several studies showing CIT induced oxidative damage in diverse cellular models from
yeast to humans [26–28,30]. As a consequence, external addition of antioxidants usually alleviates
CIT toxicity [25,48,49]. How, at the molecular level, CIT increases intracellular ROS levels is currently
unknown, however, several studies have implied an inhibition of mitochondrial respiration in
CIT-activated oxidative stress [29,31,50]. On the other hand, we demonstrate here that OTA has a much
less pronounced impact on the yeast antioxidant response at the genomic level, which is further
corroborated by specific oxidative stress reporters. Thus, oxidative stress might not be the primary
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toxicity mechanism for this mycotoxin. This divergent impact of CIT and OTA on ROS production is
in complete agreement with a recent study showing that CIT-, but not OTA-induced hepatotoxicity,
is efficiently counteracted by antioxidant treatment [49]. However, the genomic response of yeast
to OTA does include the upregulation of some antioxidant functions, which interestingly are
different from the antioxidant genes induced by CIT. OTA induces, for example, the expression
of both mitochondrial/peroxisomal and cytosolic catalases (Ctt1 and Cta1), while CIT preferentially
stimulates enzymatic functions involved in glutathione metabolism (Ecm4, Glr1, Gsh1, Gtt2, and Grx2).
Thus, apart from considerable differences in absolute ROS induction, it might be possible that CIT
and OTA produce distinct types of reactive oxygen species. These differences are striking because CIT
and OTA are structurally related mycotoxins. Both share a dihydroisocoumarin moiety as the central
structure element, which is coupled to the amino acid phenylalanine in the case of OTA. However,
a functional divergence has been suggested also with respect to the environmental conditions, which
induce the biosynthesis of CIT or OTA in their natural producer Penicillium verrucosum. Here different
stress conditions, such as oxidative or salt stress, have been shown to differentially favor the production
of one mycotoxin over the other [19,20].
Despite a large scientific effort, the critical mechanism underlying OTA cytotoxicity still remains
unknown. Oxidative stress has been widely implied in OTA action [15], but it certainly cannot
explain the carcinogenic properties of this mycotoxin. Here we confirm that OTA is able to trigger
an antioxidant response in yeast, however, ROS production is not the principle effect of OTA. This is
in agreement with recent studies, which demonstrate in rats that renal carcinogenicity and cell cycle
aberrations caused by OTA cannot be explained by oxidative damage [51,52]. Here we show that OTA
treatment causes a general deregulation of developmental genes in yeast. This effect is OTA-specific
and is not observed upon CIT exposure. The affected gene functions are related to the processes
of meiosis and sporulation, which are normally tightly repressed in haploid yeast cells such as the
strains used here for the transcriptomic experiments. Therefore, OTA seems to cause a genomic
reprogramming of a developmental process, which is normally exclusively triggered in diploid yeast
cells upon the appropriate environmental stimuli [53,54]. A tight epigenetic control, composed of
specific DNA-binding factors which recruit histone deacetylases such as the Hst1 sirtuin to meiotic and
sporulation genes, are known in yeast to assure repression of these developmental genes in haploid
cells [55–57]. How OTA can interfere with the epigenetic control of silenced genes in yeast is currently
only speculative, but opens an emerging research towards the biological function of this mycotoxin.
This is of outstanding importance because the interference with gene silencing and the function of
sirtuin histone deacetylases are hallmarks in the reprogramming of cancer cells [58,59] and thus
could provide insights into the carcinogenic function of OTA. Taken together, our results demonstrate
divergent biological effects of two related mycotoxins, which will be important for understanding their
toxicity mechanisms at the molecular level.
4. Materials and Methods
4.1. Yeast Strains and Growth Conditions
Saccharomyces cerevisiae strains used in this study were: wild type BY4741 (MATa; his3∆1; leu2∆0;
met15∆0; ura3∆0) and the mutant alleles yap1::KanMX4; skn7::KanMX4; yor1::KanMX4; pdr5::KanMX4;
snq2::KanMX4. For luciferase assays the cells were transformed with the respective lucCP+ fusion
plasmids and grown in synthetic dextrose (SD) medium which contained 0.67% yeast nitrogen base,
50 mM succinic acid pH 5.5, 2% dextrose, 100 mg/L methionine, 100 mg/L leucine, and 25 mg/L
uracil. For CIT and OTA sensitivity assays on agar plates, the respective yeast strains were grown
in SD liquid medium containing 2% dextrose to exponential growth phase and then incubated with
400 µM of CIT or OTA for the indicated time in small culture aliquots in multiwell plates at 28 ◦C.
Citrinin and ochratoxin A were purchased from Enzo Life Sciences (Farmingdale, NY, USA), and stock
solutions were prepared with DMSO as the solvent.
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4.2. Plasmid Constructions
The destabilized luciferase reporter fusions with the natural GRE2 or SOD2 promoters are
described elsewhere [60,61]. Briefly, the GRE2–lucCP+ fusion contains the upstream 940 nucleotides of
the GRE2 gene fused with the destabilized luciferase lucCP+ gene in a centromeric HIS3-containing
yeast expression plasmid. The SOD2–lucCP+ fusion contains the upstream 977 nucleotides of the SOD2
gene in the same vector backbone. The AP-1-specific destabilized luciferase reporter is described in [60].
Briefly, it contains a triple insertion of the AP-1 promoter element in the CYC1 core promoter fused
to lucCP+ in centromeric HIS3-containing yeast expression plasmids. A PDR5–luciferase expressing
reporter strain was created by integrative transformation of a PDR5–lucCP+–Kan MX DNA cassette
into yeast wild type strain BY4741 to replace the endogenous PDR5 gene with the destabilized
luciferase gene.
4.3. Live Cell Luciferase Assays
Yeast strains transformed with the respective luciferase reporter plasmids were grown at 28 ◦C
overnight in SD medium to OD = 2 at 600 nm. The culture volume necessary for the entire luciferase
assay was incubated on a roller at 28 ◦C for 90 min with 0.5 mM luciferin (Synchem, Felsberg,
Germany) from a 10 mM stock solution in Dimethylsulfoxide. The culture was then distributed in
120 µL aliquots in white 96-well plates (Nunc, Penfield, NY, USA) and growing concentrations of
CIT or OTA were added from a stock solution in DMSO. In Figure 1, 200 µM (= 50 ppm), 800 µM
(= 200 ppm), and 1600 µM (= 400 ppm) of CIT and 124 µM (= 50 ppm), 497 µM (= 200 ppm), and 994 µM
(= 400 ppm) of OTA were applied. Additionally, a constant dose of 200 µM (= 50 ppm) of CIT was
combined with growing OTA concentrations (124 µM (= 50 ppm), 497 µM (= 200 ppm), and 994 µM
(= 400 ppm)). In Figure 3, 20 µM, 40 µM, 100 µM, 200 µM, 400 µM, and 800 µM of CIT or OTA
were used. The mock-treated samples contained the same concentration of solvent without the
mycotoxin. The light emission from the culture aliquots was continuously recorded in a GloMax
Multidetection System (Promega, Madison, WI, USA) in the luminometer mode. Data were normalized
for the absolute number of cells used in the assay and processed in Microsoft Excel (2010). For each
condition, three independent culture aliquots were analyzed. The maximal luciferase activity depicted
in Figures 1C and 4B was calculated by correcting the maximal light emission for each treatment with
the value obtained for the mock-treated culture.
4.4. Yeast Sensitivity Assays
For plate assays, the yeast strains under study were grown in SD liquid medium to exponential
growth phase. 1:1, 1:10 and 1:100 dilutions of culture aliquots were then distributed in multiwell
plates and exposed for the indicated time to CIT or OTA added from stock solutions in DMSO.
Equal amounts of cells were then plated on fresh yeast extract peptone dextrose (YPD) agar plates,
which were incubated at 28 ◦C for 2 days.
4.5. Microarray Experiments and Analysis
For the comparison of the transcriptome upon various mycotoxin treatments, the pdr5 mutant
strain was used. Cells were grown in SD medium until exponential phase and then subjected to
four different toxin treatments: control (mock treated with solvent), CIT (200 ppm for 60 min), OTA
(200 ppm for 30 min), and a combination of both mycotoxins CIT/OTA (100 ppm each for 30 min).
Total RNA was prepared from four independent culture aliquots for each condition using the acid
phenol extraction method. Total RNA was further purified with the RNeasy Mini kit (Qiagen, Valencia,
CA, USA). The samples were labeled using the one-color method with Cy3 fluorophore, hybridized
to Agilent Yeast Gene Expression 8 ×15 K microarrays, and scanned with Agilent DNA Microarray
Scanner (G2505B, Agilent Technologies, Santa Clara, CA, USA). Raw data were obtained using the
Feature Extraction software 9.5.1 (Agilent Technologies, Santa Clara, CA, USA, 2007). These procedures
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were performed by the Genomic Service of the Instituto de Biología Molecular y Celular de Plantas
(IBMCP, Valencia, Spain). Data analysis was performed using GeneSpring 12.6 (Agilent Technologies,
Santa Clara, CA, USA). Data were normalized using the quantile method and then statistically analyzed
with the Student t-Test. Significant differences in gene expression were selected using a p-value < 0.05.
To avoid the detection of false positives, a multiple testing correction (Bonferroni FWER) was applied to
obtain corrected p-values. The complete dataset from all transcriptomic experiments of this publication
has been assigned accession number GSE84187 in the Gene Expression Omnibus (GEO) Database.
Significantly enriched functional gene groups were identified with the YeastMine Gene Ontology (GO)
search option of the Saccharomyces cerevisiae Genome Database (SGD).
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